Herve Le LouetMember for the European Commission of the Pharmacovigilance Risk Assessment
European Medicines Agency
HerveLe Louet is Professor of clinical Pharmacology. He is currently the head ofPharmacovigilance Federation and the Co-chair of thePharmacoepidemiology unit ofParis University Hospitals (AP-HP). He is an hepatologist by training and a PhDin Pharmacogenetic from the Paris University. He worked on liver metabolismassessment in patients with different liver conditions and on the drug inducedmitochondria toxicity. He also worked on serious cutaneous adverse reactions(SCAR), especially on causality assessment for Steven Johnson Syndrom and ToxicEpidermal Necrolysis. He has learning activities in several universitiesworldwide.
Heis a co-opted member by the European Commission of the Pharmacovigilance RiskAssessment Committee (PRAC) at the EuropeanMedicines Agency. Heis the President of the International Society of Pharmacovigilance (ISoP) andVice President of the Council for International Organizations for MedicalSciences (CIOMS). He is member of the European Network of Centers of Pharmacoepidemiologyand Pharmacovigilance (ENCEPP) and is Honorary Consultant for UppsalaMonitoring Centre (WHO). He was the advisor of the Minister of Health andSocial Security.